Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spyre Therapeutics (SYRE) Exchange Rate Effect (2020 - 2024)

Spyre Therapeutics (SYRE) has disclosed Exchange Rate Effect for 5 consecutive years, with -$15000.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Exchange Rate Effect fell 183.33% year-over-year to -$15000.0, compared with a TTM value of -$15000.0 through Sep 2025, down 150.0%, and an annual FY2024 reading of -$3000.0, down 112.0% over the prior year.
  • Exchange Rate Effect was -$15000.0 for Q4 2024 at Spyre Therapeutics, down from $16000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $47000.0 in Q4 2020 and bottomed at -$72000.0 in Q2 2022.
  • Average Exchange Rate Effect over 5 years is -$3250.0, with a median of $3500.0 recorded in 2021.
  • Peak annual rise in Exchange Rate Effect hit 1433.33% in 2022, while the deepest fall reached 1900.0% in 2022.
  • Year by year, Exchange Rate Effect stood at $47000.0 in 2020, then crashed by 93.62% to $3000.0 in 2021, then skyrocketed by 1433.33% to $46000.0 in 2022, then crashed by 60.87% to $18000.0 in 2023, then tumbled by 183.33% to -$15000.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for SYRE at -$15000.0 in Q4 2024, $16000.0 in Q3 2024, and -$4000.0 in Q1 2024.